Share on

Global Human Growth Hormone Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Application, Distribution Channel & Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa) – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 9027
Pages: 120
Formats: report pdf report excel report power bi report ppt

Global Human Growth Hormone Market Size (2022 to 2027)

As per our report, the size of the global HGH market is forecasted to reach USD 6140.31 million by 2027, growing at a CAGR of 7.50% between 2022 to 2027.

The growth hormone plays a vital role in regulating body composition and primarily spurs growth in children. However, when there is an issue producing these hormones by pituitary glands, they may not correctly develop bone and muscles. In these cases, human growth hormone injections are prescribing by doctors.

MARKET DRIVERS:

The growing number of health disorders among children, primarily due to food habits changes, is a crucial driving factor for the global HGH market to grIn addition, the rise in the awareness of the treatment procedures is propelling the growth of the market. Besides, the market is growing by a surge in the research institutes in the biotechnology field, leveraging the demand of the global human growth hormone market.

Rising neuropsychiatric cases and increasing funds made by the governments for R & D in the endocrinology sector fuel market demand. In addition, advanced technologies are introduced in the healthcare domain to improve the services' quality helping the HGH market grow. Rising regular approvals by the FDA and other government organizations, the public, and private organizations have taken some initiatives to promote the healthcare-related services and policies among the developed and under-developing companies and accelerating the human growth hormone market. Increasing older people is a one-factor fostering market demand.

Rising disposable income in the urban population and people's demand the effective treatment procedures is to set up growth opportunities for the market. The increasing consumption rate of these drugs in significant applications is likely to boost the market's growth. The growing prevalence to adopt the latest technologies in producing the pills at low cost may positively impact the HGH market demand.

MARKET RESTRAINTS:

The on-going usage of the medicines is likely to produce side-effects impacting the global HGH market growth negatively. Strict government rules in approving the drugs are restraining the market growth. The pharmaceutical companies facing ups and downs at the time of producing drugs impede the market's growth. The treatment's cost culture is very high and is likely to limit the human growth hormone market demand. Fluctuations in the productivity of drugs in pharmaceutical companies are also hindering the growth of the global human growth hormone market.

COVID-19 impact on the HGH Market:

The widespread of coronavirus has impacted medical health very mainly across the globe. The growth hormone has got important control over the immune system. The human cells consist of GH. The COVID-19 very rarely affects the children when compared with those of older people. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Analysed

By Application, Distribution Channel and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the global human growth hormone market has been segmented and sub-segmented based on application, distribution channel, and region.

Human Growth Hormone Market - By Application:

  • Growth Hormone Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader Willi Syndrome
  • Others

Based on the application, Growth hormone deficiency applications are holding the most significant shares of the market. The increasing birth rate every year and a rise in incidences of various diseases in children are accelerating the market's growth. Additionally, rising awareness among the people regarding the early-stage diagnosis and the associated treatment propel the market demand. According to the Human Growth Foundation., around 4,000 to 10,000 children have a growth hormone deficiency.

Human growth hormone market - By Distribution Channel:

  • Hospital and Retail Pharmacy
  • Online Pharmacy / ePharmacy
  • Specialty Clinics

Based on distribution channels, Hospitals and retail pharmacies are leading dominant shares of the market. Increasing construction activities of hospitals with the latest equipment are fueling the demand of the market. According to the Children’s Hospital of Philadelphia (CHOP), the growth hormone prescriptions had increased from 5.1 patients per 10,000 advantages in 2001 to 14.6 per 10,000 in 2016.

The online pharmacy segment is projected to have a significant share in the market. In existing countries like India and China, the trend of online pharmacies is increasing day by dIn addition, and the The high perforation of pharmacies is also growing in North America and Europe.

Human Growth Hormone Market - By Region:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Italy
    • Rest of EU
  • Asia Pacific
    • India
    • Japan
    • China
    • South Korea
    • ANZ
    • Rest of APAC
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of LATAM
  • Middle East
  • Africa

Geographically, The North American HGH market holds the most significant share of the global human growth hormone market with the rise in capital income and an increasing number of research institutes to develop new products. Supportive reimbursement policies and increasing government assistance in improving healthcare infrastructure are major factors propelling the market growth. The United States is leading with the largest share in the market with favorable government reimbursement policies. An increase in healthcare expenditure and technological advancements are impelling the market demand. Canada is expected to have rapid market growth. According to a published article by the Journal of Clinical Endocrinology and Metabolism in November 2016, around 6,000 Adult Growth Hormone Deficiency cases are registered every year in the U.S.

The Asia Pacific Human growth hormone market follows North America in leading dominant shares of the HGH market due to the latest technological developments. Increasing incidences of genetic disorders are ascribing to bolster the growth of this market. Also, the growing number of healthcare centers, even in rural areas, is gearing up the market's demand to the extent. Increasing occurrences of genetic disorders and a rise in healthcare expenses are fueling market growth. China is leading the market demand with the advancements in technologies, increase in disposable income. Japan is expected to have rapid growth in the human growth hormone market. Growing research and development activities with an increase in huge investments from the government are propelling market growth.

The European HGH Market will grow at the highest CAGR in foreseen years, increasing support from the public and private organizations. The increasing prevalence of the treatment of short stature is escalating the demand of the market. The market in this region is driven by factors like private and public sectors showcasing their support in bringing awareness among humans. Growing hormone deficiency disorders, increasing government expenses, and the growing significance of growth hormones for treating patients with Idiopathic Short Stature are impelling the market's demand. Germany is predicted to lead the market, followed by the U.K.

The human growth hormone market in Latin America is expected to have a steady growth rate. This is because the top companies' key players aim to increase their ability to produce to escalate the supply chain amid the rural areas, augmenting the market demand.

The Middle East and Africa HGH market anticipate having a prominent growth rate in the coming years. According to the Annals of Saudi Medicine's survey in 2015, the regular rate is registered as 0.2 per 10000 children in Saudi Arabia. In Kuwait, the growth hormone deficiency rate accounts for 38%, whereas the idiopathic short stature and Turner syndrome accounted for 20% and 12%.

KEY MARKET PLAYERS:

Companies that are playing a dominating role in the global human growth hormone market profiled in the report are Pfizer Inc., Novo Nordisk A/S, Anhui Anke Biotechnology Co. Ltd., Eli Lilly and Company, GeneScience Pharmaceuticals Co. Ltd., Genetech Inc., Novartis AG, Biopartners GmbH, Zhongshan Hygene Biopharm Co. Ltd., Merck KGaA, Ipsen S.A. and Lifetech Labs.

Please wait. . . . Your request is being processed

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample